Green Thumb Industries's revenue for the
three
months ended in Dec. 2024 was $294 Mil.
Its revenue for the trailing twelve months (TTM) ended in Dec. 2024 was $1,137 Mil.
Green Thumb Industries's Revenue per Share for the
three
months ended in Dec. 2024 was $1.19.
Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was $4.71.
Warning Sign:
Green Thumb Industries Inc revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Green Thumb Industries was 13.50% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 9.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 30.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Green Thumb Industries's highest 3-Year average Revenue per Share Growth Rate was 57.20% per year. The lowest was 9.90% per year. And the median was 20.70% per year.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Green Thumb Industries's Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, Green Thumb Industries's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Green Thumb Industries's Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Green Thumb Industries's Revenue distribution charts can be found below:
* The bar in red indicates where Green Thumb Industries's Revenue falls into.
Green Thumb Industries Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,137 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Green Thumb Industries (OTCPK:GTBIF) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Green Thumb Industries Revenue Related Terms
Thank you for viewing the detailed overview of Green Thumb Industries's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 14 states and operates 97 cannabis stores under the brand Rise. GTI is focusing its expansion on limited license states with large populations, and it does not currently export into the global medical market due to US federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RYTHM.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
GTBIF has been successfully added to your 